Team

The people behind Esma Bio.

Esma Bio is built by a team focused on translating a precision approach to endometriosis into a real therapeutic.

Nermin Ibreljic, PhD, Founder & CEO of Esma Bio

Nermin Ibreljic, PhD

Founder & CEO

Northeastern University

Founded Esma Bio to bring a precision, lesion-selective approach to endometriosis; PhD in chemical engineering from UMass Lowell; formerly at Sarepta Therapeutics.

Jon Einarsson, MD, PhD, Scientific Advisor of Esma Bio

Jon Einarsson, MD, PhD

Scientific Advisor

Founder, Freyja Healthcare

Founder of the medical-device company Freyja Healthcare; retired professor at Harvard Medical School and founding chief of Minimally Invasive Gynecologic Surgery at Brigham and Women's Hospital.

Hassan Fakih, PhD, Scientific Advisor of Esma Bio

Hassan Fakih, PhD

Scientific Advisor

UMass Chan Medical School · RNA Therapeutics Institute

Junior faculty member at UMass Chan Medical School’s RNA Therapeutics Institute; earned his PhD at McGill University and brings a focus on RNA therapeutics to Esma Bio’s scientific advisory team.

Carl Lawton, PhD, Scientific Advisor of Esma Bio

Carl Lawton, PhD

Scientific Advisor

UMass Lowell · Massachusetts BioManufacturing Center

Director of the Massachusetts BioManufacturing Center and associate professor of chemical engineering at UMass Lowell; previously a bioprocess consultant to biopharmaceutical companies.

Jerrica Breindel, PhD, Scientific Advisor of Esma Bio

Jerrica Breindel, PhD

Scientific Advisor

Quinnipiac University

Associate professor of medical sciences at Quinnipiac University; PhD in experimental pathology from Yale and former NIH postdoctoral fellow at Tufts, studying breast cancer biology.

Want to get in touch?

Get in Touch